Bibliography:

1. Lee VT, Yip SK, Tan PH, Siow WY, Lau WK, Cheng CW. Renal cell carcinoma of 4 cm or less: an appraisal of its clinical presentation and contemporary surgical management. Asian J Surg. 2006 Jan;29(1):40-3
   
   
2. Canfield SE, Kamat AM, Sanchez-Ortiz RF, Detry M, Swanson DA, Wood CG. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol. 2006 Mar;175(3 Pt 1):864-9
   
   
3. Konety BR, Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. Urol Oncol. 2006 Jan-Feb;24(1):87-8
   
   
4. Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stockle M. Elective Nephron Sparing Surgery Should Become Standard Treatment for Small Unilateral Renal Cell Carcinoma: Long-term Survival Data of 216 Patients.Eur Urol. 2006 Feb;49(2):308-13.
   
   
5. Phelan MW, Perry KT, Gore J, Schulam PG. Laparoscopic partial nephrectomy and minimally invasive nephron-sparing surgery.Curr Urol Rep. 2003 Feb;4(1):13-20.
   
   
6. Murthy SC, Kim K, Rice TW, Rajeswaran J, Bukowski R, DeCamp MM, Blackstone EH. Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? Ann Thorac Surg. 2005 Mar;79(3):996-1003
   
   
7. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005 Jul;185(1):64-71
   
   
8. Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol. 2005 Jul;185(1):72-80.
   
   
9. Merkle EM, Nour SG, Lewin JS. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology. 2005 Jun;235(3):1065-71
   
   
10. Ahrar K, Matin S, Wood CG, Wallace MJ, Gupta S, Madoff DC, Rao S, Tannir NM, Jonasch E, Pisters LL, Rozner MA, Kennamer DL, Hicks ME. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol. 2005 May;16(5):679-88
    
    
11. Lee DI, McGinnis DE, Feld R, Strup SE. Retroperitoneal laparoscopic cryoablation of small renal tumors: intermediate results. Urology. 2003 Jan;61(1):83-8.
    
    
12. Halperin EC, Harisiadis L. The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer. 1983 Feb 15;51(4):614-7.
    
    
13. Wronski M, Maor MH, Davis BJ, Sawaya R, Levin VA. External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):753-9.
    
    
14. DiBiase SJ, Valicenti RK, Schultz D, Xie Y, Gomella LG, Corn BW. Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol. 1997 Sep;158(3 Pt 1):746-9.
    
    
15. Lee J, Hodgson D, Chow E, Bezjak A, Catton P, Tsuji D, O'Brien M, Danjoux C, Hayter C, Warde P, Gospodarowicz MK. A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. Cancer. 2005 Nov 1;104(9):1894-900
    
    
16. Cannady SB, Cavanaugh KA, Lee SY, Bukowski RM, Olencki TE, Stevens GH, Barnett GH, Suh JH. Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study. Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):253-8.
    
    
17. Rost A, Brosig W. Preoperative irradiation of renal cell carcinoma. Urology. 1977 Nov;10(5):414-7.
    
    
18. Malkin RB. Regression of renal carcinoma following radiation therapy. J Urol. 1975 Nov;114(5):782-3.
    
    
19. Frydenberg M, Gunderson L, Hahn G, Fieck J, Zincke H. Preoperative external beam radiotherapy for locally advanced primary or recurrent renal malignancies. J Urol. 1994 Jul;152(1):15-21.
    
    
20. Peeling WB, Mantell BS, Shepheard BG. Post-operative irradiation in the treatment of renal cell carcinoma. Br J Urol. 1969 Feb;41(1):23-31
    
    
21. Aref I, Bociek RG, Salhani D. Is post-operative radiation for renal cell carcinoma justified? Radiother Oncol. 1997 May;43(2):155-7
    
    
22. Kao GD, Malkowicz SB, Whittington R, D'Amico AV, Wein AJ. Locally advanced renal cell carcinoma: low complication rate and efficacy of postnephrectomy radiation therapy planned with CT. Radiology. 1994 Dec;193(3):725-30.
    
    
23. Wersall PJ, Blomgren H, Lax I, Kalkner KM, Linder C, Lundell G, Nilsson B, Nilsson S, Naslund I, Pisa P, Svedman C. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol. 2005 Oct;77(1):88-95
    
    
24. Noel G, Valery CA, Boisserie G, Cornu P, Hasboun D, Marc Simon J, Tep B, Ledu D, Delattre JY, Marsault C, Baillet F, Mazeron JJ. LINAC radiosurgery for brain metastasis of renal cell carcinoma. Urol Oncol. 2004 Jan-Feb;22(1):25-31
    
    
25. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg. 2003 Feb;98(2):342-9.
    
    
26. Goyal LK, Suh JH, Reddy CA, Barnett GH. The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):1007-12
    
    
27. Gerszten PC, Burton SA, Ozhasoglu C, Vogel WJ, Welch WC, Baar J, Friedland DM. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine. 2005 Oct;3(4):288-95
    
    
28. Ponsky LE, Crownover RL, Rosen MJ, Rodebaugh RF, Castilla EA, Brainard J, Cherullo EE, Novick AC. Initial evaluation of CyberKnife® technology for extracorporeal renal tissue ablation. Urology. 2003 Mar;61(3):498-501